We know genetics can influence how people respond to medications, but how often does that affect care in the real world? In a recent study, researchers analyzed genomic and electronic health record data from more than 226,000 participants in Geisinger's MyCode to better understand the impact of genetics on adverse drug reactions. Key findings: 🧬93.7% of patients carried at least one genetic variant that could affect medication response. 💊More than 44% were prescribed a medication that conflicted with their genetic risk profile. 👨‍👩‍👧‍👦Patients with a genetic mismatch were 1.4 times more likely to experience an adverse drug reaction. 📄These mismatches accounted for nearly 30% of adverse drug reactions observed. Integrating pharmacogenomic testing into routine care could help identify medication risks earlier and prevent adverse drug reactions before a patient takes their first dose. sciencedirect.com/science/ar…

🗣️Don't miss the next #MyCode Genomic Screening and Counseling Program Grand Rounds "One Size May Not Fit All: Translating Genomic Risk into Individualized Care" Presented by: Hannah Ryba, MS, CGC, Genetic Counselor I 🗓️October 12th 🕛12:00-1:00 PM

Today, we celebrate the dedicated research administrators who work behind the scenes to help research thrive. From navigating complex regulations and budgets to supporting researchers, managing grants and keeping projects moving forward, research administrators are essential partners in turning ideas into impact. Thank you for your expertise, problem-solving, collaboration and unwavering commitment to advancing research. Your work makes a difference every day! Here’s to the research administrators who make discovery possible. 💫💙👏 #ResearchAdministratorsDay @NCURA

Congratulations to Max Freid Kramer on being named an inaugural fellow of Georgetown’s Blood and Plasma Research Group Fellowship! 👏 This new fellowship supports early-career scholars whose research focuses on blood products and related areas. We’re proud to see Max represent Geisinger in this exciting opportunity and look forward to the impact of his work. ➡️Learn more about the fellowship here: gisme.georgetown.edu/georget…

New research published in @Nature identifies #FNIP1 as a promising therapeutic target for obesity, fatty liver disease and other cardiometabolic conditions. Co-authored by Geisinger’s Christopher D. Still, DO, the study found rare FNIP1 variants were linked to lower liver fat, improved glycemic control and reduced cardiometabolic disease risk. The findings highlight the power of combining human genetics through #MyCode with translational science to uncover new pathways for patient care. 📄Read the study here: nature.com/articles/d41586-0…

👀Check out the next #MyCode Genomic Screening and Counseling Program Grand Rounds Presentation: "The Helix Research Network in Action: From Validation to Discovery in Clinicogenomic Research" Presented by: Kelly Schiabor Barrett, PhD, Senior Staff Scientist, Helix and Matthew Levy, PhD, Staff Research Scientist, Helix 🗓️September 14th 🕛12:00-1:00 PM ET

Every child deserves to grow up safe. Geisinger is expanding child sexual abuse prevention efforts in Northumberland County with support from a three-year PA Children’s Trust Fund (CTF) grant. The initiative will give schools, community organizations and families the tools and confidence to recognize warning signs and help prevent abuse. 📖Read more from FOX56: fox56.com/news/local/geising…

📢Check out the next #MyCode Genomic Screening and Counseling Program Grand Rounds "Genomic Screening in the VA: Insights from ProGRESS and MVP-ROAR" Presented by: Jason L. Vassy, MD, MPH, MS, Director, Genomes2Veterans Research Program, VA Boston Healthcare System and Associate Professor of Medicine, Harvard Medical School & Morgan Danowski, MS, CGC, Genetic Counselor and Project Manager, Genomes2Veterans Research Program, VA Boston Healthcare System 🗓️July 13th 🕛12:00-1:00 PM ET

🗣️Don't miss "Tuberous Sclerosis Complex Identified Through Population Screening" by Gretchen Urban and Dr. Alexander Chang #MyCode Genomic Screening and Counseling Program Grand Rounds presentation on June 8th @ noon.

🌠Every scientific breakthrough starts with a question—and a clinical trial.💡On #ClinicalTrialsDay, we celebrate the patients, researchers, and teams who make innovation possible and drive safer, more effective treatments for all. 🧑‍🔬🩵 #Innovation #ClinicalResearch @ACRPDC

We celebrate #DNADay and the discovery of the 🧬double helix! We applaud all our geneticists, genetic counselors, clinicians, researchers, and staff working in the field to advance the science and improve outcomes for our patients and communities.🔬👏

👀👉The next #MyCode Genomic Screening and Counseling Program Grand Rounds on May 11th at noon “We found important information in your DNA🧬: Process and Outcomes of #MyCode Genomic Screening Results Disclosure" Presenters: Rachel Schwiter, MGC and Allison Clemens, BS

🗣️Don't miss the April 13th #MyCode Genomic Screening and Counseling Program Grand Rounds "Hereditary Paraganglioma and Pheochromocytoma Management in the #MyCode Population" Presented by: Alyson Floyd, MS, CGC & Brian C. Jameson, DO 🕛12:00-1:00 PM